Trial Profile
Bioequivalence of Two Pediatric Formulations vs Adult Tablet Formulation of Elvitegravir
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2014
Price :
$35
*
At a glance
- Drugs Elvitegravir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 31 Mar 2014 New trial record
- 06 Mar 2014 Results presented at the 21st Conference on Retroviruses and Opportunistic Infections.